Allarity Therapeutics Inc (ALLR) concluded trading on Wednesday at a closing price of $1.00, with 4.33 million shares of worth about $4.33 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -70.41% during that period and on Wednesday the price saw a gain of about 17.58%. Currently the company’s common shares owned by public are about 4.43M shares, out of which, 3.39M shares are available for trading.
Stock saw a price change of -1.96% in past 5 days and over the past one month there was a price change of 0.02%. Year-to-date (YTD), ALLR shares are showing a performance of -14.53% which decreased to -99.52% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.68 but also hit the highest price of $216.00 during that period. The average intraday trading volume for Allarity Therapeutics Inc shares is 2.65 million. The stock is currently trading 7.39% above its 20-day simple moving average (SMA20), while that difference is down -3.27% for SMA50 and it goes to -71.58% lower than SMA200.
Allarity Therapeutics Inc (NASDAQ: ALLR) currently have 4.43M outstanding shares and institutions hold larger chunk of about 2.36% of that.
The stock has a current market capitalization of $4.43M and its 3Y-monthly beta is at 0.00. It has posted earnings per share of -$883.45 in the same period. It has Quick Ratio of 2.75 while making debt-to-equity ratio of 0.10. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ALLR, volatility over the week remained 19.23% while standing at 15.29% over the month.
